Atea Pharmaceuticals Inc. (AVIR): Price and Financial Metrics
AVIR Price/Volume Stats
| Current price | $3.16 | 52-week high | $4.60 |
| Prev. close | $3.14 | 52-week low | $2.77 |
| Day low | $3.10 | Volume | 182,000 |
| Day high | $3.16 | Avg. volume | 296,035 |
| 50-day MA | $3.47 | Dividend yield | N/A |
| 200-day MA | $3.70 | Market Cap | 266.90M |
AVIR Stock Price Chart Interactive Chart >
Atea Pharmaceuticals Inc. (AVIR) Company Bio
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
AVIR Price Returns
| 1-mo | -11.24% |
| 3-mo | -18.97% |
| 6-mo | -13.66% |
| 1-year | 12.86% |
| 3-year | -60.30% |
| 5-year | N/A |
| YTD | 3.61% |
| 2023 | -36.59% |
| 2022 | -46.20% |
| 2021 | -78.60% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...